Integrated Prevention and Treatment Strategies for Needle-Induced Syncope in Primary Healthcare
Abstract
TCM syndrome differentiation, modern pharmaceutical technologies, probioticherb combinations, and VR interventions, while elucidating
underlying mechanisms. Methods: Analysis of TCM syndrome patterns, autonomic nervous system mechanisms ("braingutheart axis"),
and limitations of existing protocols. Proposed solutions were evaluated for primary healthcare adaptability. Results: Three TCM syndrome
types were identified: (1) Qi deficiency and blood weakness; (2) mental restlessness; and (3) phlegmturbidity obstruction. Modern technologies enhanced herbal bioavailability (e.g., cyclodextrin inclusion increased oral bioavailability threefold). ProbioticAstragalus polysaccharide
combinations provided low-cost alternatives. VR reduced prodromal symptoms by 40% via attention competition. A three-stage prevention
strategy was established. Conclusion: Integrated strategies bridge TCMWestern medicine gaps. Successful translation requires standardized
syndrome differentiation, accessible technologies, and adolescent-friendly VR interventions.
Keywords
Full Text:
PDFReferences
[1] China Medical Information Query Platform. Clinical Guidelines for Vasovagal Syncope (2024 Edition) [S]. Beijing: China Medical Science Press, 2024.
[2] Xie J, Li L, Zhang H. Incidence and Risk Factors of Needle-Induced Syncope in Adolescents Undergoing Venipuncture [J]. J. Pediatr.
Nurs., 2023, 68: 45-52.
[3] McLenon J, Rogers M. Needle Phobia: A Review of Etiology, Diagnosis, and Treatment [J]. J. Anxiety Disord., 2019, 62: 106-115.
[4] Ding Y, Wang H, Chen L. Modern Pharmaceutical Technologies Improve Bioavailability of Traditional Chinese Medicine Formulations
[J]. J. Ethnopharmacol., 2020, 259: 112987.
[5] Duan M, Zhang Y, Li J. Pathophysiological Mechanisms and Clinical Management of Needle-Induced Vasovagal Syncope [J]. Am. J.
Cardiol., 2025, 158: 78-86.
[6] Kallel S, Ben Amor I, Jemli M. Virtual Reality and Nanopharmaceuticals: Innovative Approaches for Pain and Anxiety Management in
Clinical Procedures [J]. Int. J. Pharm., 2025, 678: 121654.
[7] Kardon R, Smith S, Jones T. Autonomic Nervous System Response to Virtual Reality Relaxation in Patients with Needle Phobia [J]. Auton. Neurosci., 2022, 238: 103089.
[8] Chinese Society of Traditional Chinese Medicine. Guidelines for TCM Syndrome Differentiation and Treatment of Syncope (2024 Edition) [S]. Beijing: China Traditional Chinese Medicine Press, 2024.
[9] Luo H, Chen F, Wang Y. Correlation Between TCM "Heart-Small Intestine" Theory and Brain-Gut Axis Function [J]. Chin. J. Integr.
Med., 2023, 29(7): 512-518.
[10] Li J, Zhang L, Wang Z. Astragalus Polysaccharide Regulates Gut Microbiota and Improves Autonomic Nervous System Function in
Rats with Vasovagal Syncope [J]. J. Ethnopharmacol., 2009, 124(3): 456-462.
[11] Lin C, Liu Y, Chen J. Probiotic-Astragalus Polysaccharide Combination Regulates the Brain-Gut-Vagus Axis to Alleviate NeedleInduced Anxiety [J]. J. Microbiol. Biotechnol., 2025, 35(2): 789-798.
[12] Bhadoria A, Singh R, Mishra S. Challenges in Integrating Traditional Medicine into Primary Healthcare: A Global Perspective [J].
Health Policy Plan., 2025, 40(3): 345-354.
[13] Zhang Y, Li M, Zhao J. Cyclodextrin Inclusion Complex of Ginsenosides: Improved Bioavailability and Taste Masking [J]. Carbohydr.
Polym., 2022, 287: 119345.
[14] Wei C, Zhang H, Li N. Self-Assembling Nanospheres from Coptis-Scutellaria Herbal Pair: Preparation and In Vivo Efficacy [J]. J. Nanobiotechnol., 2025, 23(1): 42.
[15] He X, Wang L, Zhang Q. Transdermal Delivery of Ginsenoside Rg1 via Neiguan Point for Anxiety Relief in Needle Phobia Patients [J]. J.
Pharm. Pharmacol., 2011, 63(8): 1023-1030.
[16] Zhou Y, Li J, Chen H. Azone-Enhanced Transdermal Absorption of Ginsenoside Rg1: In Vitro and In Vivo Evaluation [J]. Pharm. Dev.
Technol., 2004, 9(4): 321-328.
[17] Malbos E, Mourgues I, Navarro O. Virtual Reality Relaxation Reduces Prodromal Symptoms of Needle-Induced Syncope in Adolescents [J]. J. Adolesc. Health, 2025, 76(2): 289-295.
[18] Ashmore J, Smith K, Jones P. Low-Cost Virtual Reality for Anxiety Reduction in Resource-Limited Primary Healthcare Settings [J].
PLoS One, 2019, 14(12): e0226543.
[19] Wang Y, Li G, Zhang J. Methodology for Clinical Translation of Integrated Chinese-Western Medicine Strategies in Primary Healthcare
[J]. Chin. J. Clin. Pharmacol., 2024, 40(11): 1234-1238.
[20] Ministry of Health of the People's Republic of China. National Primary Healthcare Development Plan (2024-2030) [Z]. 2024.
[21] Korteling J, van der Straaten P, IJsselsteijn W. Virtual Reality as a Non-Pharmacological Intervention for Anxiety in Medical Procedures: A Systematic Review [J]. Comput. Biol. Med., 2025, 179: 107432.
DOI: http://dx.doi.org/10.70711/pmr.v3i5.8992
Refbacks
- There are currently no refbacks.
